ABSTRACT
Maternal-to-fetal transmission of the murine lactate dehydrogenase-elevating virus (LDV) has been previously shown to be regulated by maternal immunity as well as gestational age. For the present study, the role of maternal immunity in placental and umbilical cord virus protection was studied, and virus targeting of umbilical cord and fetal macrophages was correlated with expression of the F4/80 macrophage phenotypic marker. The results showed that LDV-infected macrophages appeared in umbilical cord by 24 h post-infection of pregnant mice, and some LDV-infected macrophages displayed the F4/80 phenotype. This potential reservoir of virus for the fetus was inhibited by passive immunization of pregnant mice with IgG anti-LDV antibodies, which rapidly concentrated in the placenta and umbilical cord. Probing of umbilical cord cells with antibodies directed at MHC genetic markers demonstrated the presence of both maternal and fetal cells in umbilical cords. A strong developmental correlation was observed between fetal F4/80 expression and LDV susceptibility, at about 13.6 days of gestation. These results demonstrate immune suppression of free and cell-associated virus in umbilical cord, thus defining a potentially important mechanism for immune protection of the fetus from transplacental virus infection. The results also clarify the developmental basis for fetal susceptibility to LDV infection.
Subject(s)
Antigens, Differentiation/biosynthesis , Arterivirus Infections/transmission , Fetal Blood/virology , Infectious Disease Transmission, Vertical , Lactate dehydrogenase-elevating virus/immunology , Maternal-Fetal Exchange/immunology , Animals , Animals, Outbred Strains , Antibodies, Viral/biosynthesis , Antibodies, Viral/immunology , Antigens, Differentiation/immunology , Arterivirus Infections/immunology , Disease Susceptibility/immunology , Disease Susceptibility/virology , Female , Fetal Blood/immunology , Fetal Diseases/immunology , Fetal Diseases/virology , Immunization, Passive , Lactate dehydrogenase-elevating virus/pathogenicity , Lactate dehydrogenase-elevating virus/physiology , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/virology , Mice , Mice, Inbred ICR , Pregnancy , Pregnancy Complications, Infectious/immunology , Pregnancy Complications, Infectious/virology , Viremia/immunologyABSTRACT
Age-dependent poliomyelitis (ADPM) is a neuroparolytic disease which results from combined infection of susceptible mice with lactate dehydrogenase-elevating virus (LDV) and murine leukemia virus (MuLV). The present study examined the effects of interferon-gamma (IFN-gamma) treatment on the incidence of ADPM, replication of LDV and MuLV and anti-LDV immunity. IFN-gamma treatment of ADPM-susceptible C58/M mice protected them from paralytic disease, but had no detectable effect on the IgG anti-LDV response or LDV viremia. IFN-gamma-mediated protection from ADPM correlated with reduced expression of LDV RNA, but not MuLV RNA, in the spinal cords of C58/M mice. These results confirm that spinal cord LDV replication is the determinant of ADPM and demonstrate that cytokine-mediated inhibition of LDV replication in the central nervous system prevents neuroparalytic disease.
Subject(s)
Aging/pathology , Interferon-gamma/pharmacology , Lactate dehydrogenase-elevating virus/drug effects , Leukemia Virus, Murine/drug effects , Poliomyelitis/prevention & control , Animals , Antibody Formation , Genetic Predisposition to Disease , Immunoglobulin G/biosynthesis , Lactate dehydrogenase-elevating virus/immunology , Lactate dehydrogenase-elevating virus/isolation & purification , Mice , Mice, Mutant Strains , RNA, Viral/genetics , Spinal Cord/virologyABSTRACT
Placental and fetal infections with lactate dehydrogenase-elevating virus (LDV) were determined by virus titration, indirect fluorescence antibody (IFA), and in situ hybridization with cDNA probes. Experiments were designed to determine the effects of gestational age, timing of maternal LDV infection, and immunological (antibody and cytokine) factors on mouse placental and fetal LDV infection. Virus infection of the placenta was detected at high levels (almost all placentas infected) within 24 h post-maternal infection (p.m.i.), whereas fetal LDV infection was detected only at a low level by 24 h p.m.i. The percentage of fetuses becoming LDV infected progressively increased between 24 and 72 h p.m.i. When fetal infection was studied at 72 h p.m.i., earlier gestational ages (9-11 days) were associated with fetal resistance to infection, whereas between 12.5 and 15 days of gestation, virus infection was detected in 50-71% of fetuses. Maternal treatment with interferon-gamma (IFN-gamma) or anti-LDV monoclonal antibodies was associated with reduced rates of fetal, but not placental, LDV infection. These results demonstrate that both developmental and immunological factors are important in the regulation of transplacental LDV infection.
Subject(s)
Arterivirus Infections/virology , Fetus/virology , Lactate dehydrogenase-elevating virus/isolation & purification , Placenta/virology , Animals , Antibodies, Monoclonal/pharmacology , Antibodies, Viral/immunology , Antibodies, Viral/pharmacology , Antiviral Agents/pharmacology , Arterivirus Infections/pathology , Arterivirus Infections/prevention & control , Female , Fetus/pathology , Fluorescent Antibody Technique, Indirect , Gestational Age , Infectious Disease Transmission, Vertical , Interferon-gamma/pharmacology , Lactate dehydrogenase-elevating virus/genetics , Lactate dehydrogenase-elevating virus/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Placenta/pathology , Pregnancy , Time FactorsSubject(s)
Bovine Virus Diarrhea-Mucosal Disease/immunology , CD8 Antigens/analysis , Malignant Catarrh/immunology , T-Lymphocytes/immunology , Vasculitis/veterinary , Animals , Bovine Virus Diarrhea-Mucosal Disease/complications , Bovine Virus Diarrhea-Mucosal Disease/pathology , Cattle , Female , Immunophenotyping/veterinary , Malignant Catarrh/complications , Malignant Catarrh/pathology , Vasculitis/immunology , Vasculitis/microbiology , Vasculitis/pathologyABSTRACT
Cattle were immunized with vaccines containing modified-live or inactivated bovine respiratory syncytial virus (BRSV) and lymphocyte proliferative responses and cytokine secretion were monitored sequentially. Compared to pre-inoculated values, significant increases in proliferative responses to modified-live BRSV were detectable by Day 7 after the primary immunization with the vaccine containing inactivated BRSV, and by 7 days after the second immunization with modified-live virus. After a third immunization with the respective vaccines, proliferative responses to live BRSV were significantly higher in the group that received modified-live vaccine compared to the group that received inactivated vaccine. Proliferative responses to live BRSV corresponded with the presence of interleukin-2 (IL-2) in the supernatants from BRSV-stimulated leukocyte cultures and there were significantly higher levels of IL-2 in cultures from the group that received modified-live BRSV. An interferon species with the characteristics of interferon-alpha was also present in the supernatants from leukocyte cultures and there were no significant differences between the groups of vaccines. The predominant phenotype of proliferating cells in BRSV-stimulated leukocyte cultures derived from both groups of bovine vaccines was a BoCD4+ T-lymphocyte. These in vitro data suggest that both types of vaccines are capable of stimulating cell-mediated immune responses to BRSV in cattle.
Subject(s)
Cattle Diseases/immunology , Respiratory Syncytial Viruses/immunology , Respirovirus Infections/veterinary , Viral Vaccines/immunology , Animals , Cattle , Cells, Cultured , Immunity, Cellular/immunology , Immunoenzyme Techniques/veterinary , Immunophenotyping/veterinary , Interferon-alpha/biosynthesis , Interleukin-2/biosynthesis , Leukocytes, Mononuclear/immunology , Lymphocyte Activation/immunology , Respirovirus Infections/immunology , Vaccines, Attenuated/immunology , Vaccines, Inactivated/immunologyABSTRACT
Cattle were immunized with vaccines containing modified-live or inactivated bovine respiratory syncytial virus (BRSV) and serum antibody responses were analyzed. Compared with preinculation values, at Day 14 after two biweekly immunizations with modified-live or inactivated vaccines there were significant increases in BRSV-specific titers in the sera of cattle that received both types of vaccines, as determined by a whole cell ELISA. Using a blocking ELISA and radioimmune precipitation it was determined that there was recognition of the fusion (F) protein by antibodies from cattle that received both types of BRSV antigens: however, virus neutralization assays revealed that only cattle that received modified live virus, either in monovalent or polyvalent vaccines, developed neutralizing antibodies to BRSV after two immunizations. These results indicate that inactivation of BRSV can lead to a dissociation between serological recognition of the F protein and virus neutralization in vaccinated cattle.
Subject(s)
Antibodies, Viral/immunology , Cattle Diseases/immunology , Respiratory Syncytial Viruses/immunology , Respirovirus Infections/veterinary , Viral Vaccines/immunology , Animals , Antibodies, Viral/blood , Antibody Specificity/immunology , Cattle , Electrophoresis, Polyacrylamide Gel/veterinary , Enzyme-Linked Immunosorbent Assay/veterinary , Neutralization Tests/veterinary , Radioimmunoprecipitation Assay/veterinary , Respirovirus Infections/immunology , Vaccines, Attenuated/immunology , Vaccines, Inactivated/immunologyABSTRACT
Rumen contents of 2 heifers with acute polioencephalomalacia (cerebrocortical necrosis) were compared with rumen contents from a healthy steer fed a fibrous diet. Also examined were (i) the quantitative nature of the predominant rumen microflora, (ii) the distribution of morphologic types of bacteria in the rumen contents, (iii) the extent that morphologic groups produced or degraded thiamine, and (iv) the cumulative effects of metabolic activities of the predominant rumen bacteria concerning the net production or degradation of thiamine. The differences in the frequency of occurrence of particular bacterial morphologic groups, the extent of growth, and the amount of thiamine metabolism in relationship to growth were also evaluated. The cumulative thiamine metabolism of the predominant bacteria associated with the rumen of polioencephalomalacia-affected heifers led to substantial net thiamine destruction, whereas metabolism associated with the rumen of a normal steer led to thiamine production. Polioencephalomalacia may occur as a consequence of alteration of the metabolic activities of the predominant resident ruminal bacteria associated with diseased cattle.